• Sonuç bulunamadı

Biomechanical Study of Bone-Patellar Tendon-Bone and Bone-ACL-Bone Grafts

N/A
N/A
Protected

Academic year: 2021

Share "Biomechanical Study of Bone-Patellar Tendon-Bone and Bone-ACL-Bone Grafts"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

骨-髕骨韌帶-骨與骨-前十字韌帶-骨移植之生物

力學研究

Biomechanical Study of Bone-Patellar

Tendon-Bone and Bone-ACL-Bone Grafts

何為斌

Ho WP;Liau JJ;Cheng CK

摘要

本研究探討骨-髕骨韌帶-骨與骨-前十字韌帶-骨作為前十字韌帶重建的移 植材料的生物力學特性,研究方法以20隻Rottweier狗為實驗對象,其中18隻為實 驗組,2隻為控制組,實驗組又區分為第一組:重建後三個月;第二組:六個月; 第三組:十二個月犧牲做拉伸實驗以比較這兩種移植材料的最大抗拉強度。在骨 -髕骨韌帶-骨組最大的抗拉強度三個月為117.1牛頓、六個月為232.8牛頓、十 二個月為777.4牛頓;在骨-前十字韌帶-骨組最大的抗拉強度三個月為458.7牛 頓、六個月為814.8牛頓、十二個月為1064.1牛頓;而控制組前十字韌帶最大抗拉 強度為1461.7牛頓。本研究證實骨-前十字韌帶-骨作為前十字韌帶的重建材料 比骨-髕骨韌帶-骨在生物力學的特性上較佳。

Abstract

Twenty Rottweier dogs were included to investigate the biomechanical behaviors of bone-patellar tendon-bone and bone-ACL-bone grafts for ACL reconstruction. Those dogs were further divided into three experimental groups and one control group. The group Ⅰ was sacrificed three months after ACL reconstruction, the group Ⅱ, six months and the group Ⅲ, twelve months. For bone-patellar tendon-bone graft, the mean maximum tensile strength was 117.1 N in the group Ⅰ, 232.8 N in the group Ⅱ and 777.4 N in the group Ⅲ. For bone-ACL-bone autograft, the mean maximum tensile strength was 458.7 N in the group Ⅰ, 814.4 N in the group Ⅱ and 1064.1 N in the group Ⅲ. The mean maximum tensile strength was 1461.7 N in the control group. This study revealed the

bone-ACL-bone graft has a better result than bone-patellar tendon-bone graft for ACL reconstruction in the dog model.

Referanslar

Benzer Belgeler

 A significant (P<0.05) increase of 20% in MTT assay and micro protein determination were observed in os teoblasts treated with (-)-epicatechin- 3-O-b-D-allopyranoside or

脊椎病變(軟骨突出; 骨折),膝之半月軟骨或十字韌帶之立體結構於臨床上具特殊重要性,且運動傷害; 意外傷;

脊椎病變(軟骨突出; 骨折),膝之半月軟骨或十字韌帶之立體結構於臨床上具特殊重要性,且運動傷害; 意外傷;

In our experimental model, mesenchymal progenitor cells (MPCs) pre-treated with dexamethasone and TGF-β1 for 7 days, to induce chondrogenic differentiation, and then treated

In our experimental model, mesenchymal progenitor cells (MPCs) pre-treated with dexamethasone and TGF-β1 for 7 days, to induce chondrogenic differentiation, and then treated

In our experimental model, mesenchymal progenitor cells (MPCs) pre-treated with dexamethasone and TG F-β1 for 7 days, to induce chondrogenic differentiation, and then treated

因此 PCL 的重建,其固定物的起始

The second one is to evaluate the degree of biodegradation of this material at the time intervals we have planned, including the change of weight , three-point bending